Evaluation of Novel Multiplex Antibody Kit for Human Immunodeficiency Virus 1/2 and Hepatitis C Virus Using Sol-Gel Based Microarray
Table 2
Summary results on anti-HIV and anti-HCV on samples of panel 2. (a) Performance comparison of the HIV tests with regard to panel 2 (seroconversion panel). (b) Performance comparison of the HCV tests with regard to panel 2 (seroconversion panel).
(a)
HIV panel
Bleed day of first positive result by the Hi3-1 Multiplex kit
Bleed day of first positive result by the Architect HIV Ag/Ab Combo
PRB955
12
12
PRB958
15
7
PRB966
48
44
PRB967
17
17
PRB968
26
26
PRB972
18
18
Total number of bleeds
43
43
Detected bleeds
15
18
(b)
HCV panel
Bleed day of first positive result by the Hi3-1 Multiplex kit
Bleed day of first positive result by the Architect anti-HCV
PHV912
4
7
PHV913
0
7
PHV917
85
85
PHV920
7
16
PHV921
0
7
PHV922
3
3
PHV923
21
21
PHV924
59
59
PHV925
27
27
Total number of bleeds
59
59
Detected bleeds
42
35
The number of detected bleeds was calculated. Discrepant results between the Hi3-1 and Architect system are highlighted in bold.
